No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ELV240621P500000
- 0.05
- -0.75-93.75%
15min DelayClose Jun 20 16:00 ET
0.42High0.05Low
0.42Open0.80Pre Close20 Volume268 Open Interest500.00Strike Price767.00Turnover52.14%IV6.51%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0095Delta0.0016Gamma10695.80Leverage Ratio-0.0500Theta-0.0001Rho-101.61Eff Leverage0.0076Vega
Intraday
- 5D
- Daily
News
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 6.3% on an annualized basis producing an average annual return of 17.18%. Currently, Elevance Health has a market capit
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Elevance Health, Inc. (ELV): A Feminist Stock That Benefits From Health Care Growth
Elevance Health Insiders Sold US$9.2m Of Shares Suggesting Hesitancy
CMS to Recalculate Ratings for 2024 Medicare Advantage Plans
Comments
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
High insider ownership aligns management incentives with shareholders, but recent insider share sales, especially below current price, are concerning. Lack of insider purchases over the last year adds to the unease.
1
Market optimism grows for the stock after years of progress. Despite slowing share price gains, the business may continue to execute with prowess.
Elevance Health's performance is commendable, particularly its high rate of return and significant reinvestment into its business, which has led to impressive earnings growth. Analysts expect the company's earnings to gain momentum in the future.
Elevance's 2024 earnings guidance and cost control in its Medicare business may reassure investors. CEO Gail Boudreaux expects improved earnings in the Medicare business in 2024.
Read more
binjh : Well, they do say sell in May and go away.
Power Bull : Good update. Keep it coming
eldritch : market is bleeding right now bears got it on lock for now it can only rise
KL6808 : Bear trap, value trap or whatsoever, I belong to the old school where only death and taxes are certain.
If history always repeat itself, then no one will lose a dime.
Ask yourself what you are, intraday, medium, long term trader, what are your core holdings and what are your tactical, speculative bets?
It's always good to take some money off the table if the underlying hit their ATH. If you ain't so lucky as some are approaching their ATL, then should you cut some losses?
Meanwhile, some guru, big fund managers are talking about three rate cuts this year, but don't bet on it that they will come soon. Even if they do, or if the cuts are more than 25bp, then you better be worried that FED might have seen something coming, eg a worst off recession and a potential harder landing than the markets expect.